학술논문

SARS-CoV-2 Epidemiology on a Public University Campus in Washington State
MAJOR ARTICLE
Document Type
Clinical report
Source
Open Forum Infectious Diseases. November 2021, Vol. 8 Issue 11
Subject
Greece
Language
English
ISSN
2328-8957
Abstract
Universities are characterized by congregate living, in-person learning, and active social environments, all of which may contribute to rapid spread of infectious diseases. Between May and August 2020, persons aged [...]
Background. We aimed to evaluate a testing program to facilitate control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission at a large university and measure spread in the university community using viral genome sequencing. Methods. Our prospective longitudinal study used remote contactless enrollment, daily mobile symptom and exposure tracking, and self-swab sample collection. Individuals were tested if the participant was exposed to a known SARS-CoV-2-infected person, developed new symptoms, or reported high-risk behavior (such as attending an indoor gathering without masking or social distancing), if a member of a group experiencing an outbreak, or at enrollment. Study participants included students, staff, and faculty at an urban public university during the Autumn quarter of 2020. Results. We enrolled 16 476 individuals, performed 29 783 SARS-CoV-2 tests, and detected 236 infections. Seventy-five percent of positive cases reported at least 1 of the following: symptoms (60.8%), exposure (34.7%), or high-risk behaviors (21.5%). Greek community affiliation was the strongest risk factor for testing positive, and molecular epidemiology results suggest that specific large gatherings were responsible for several outbreaks. Conclusions. A testing program focused on individuals with symptoms and unvaccinated persons who participate in large campus gatherings may be effective as part of a comprehensive university-wide mitigation strategy to control the spread of SARS-CoV-2. Keywords. COVID-19 testing; genome sequencing; outbreak; SARS-CoV-2; university.